Insulin-like growth factor 1 receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma

被引:14
|
作者
Chaves, EBM
Brum, IS
Stoll, J
Capp, E
Corleta, HVE
机构
[1] Univ Fed Rio Grande Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Dept Physiol, Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande Sul, Dept Gynecol & Obstet, Porto Alegre, RS, Brazil
[4] Clin Gerar Fertilizacao Assistida, Porto Alegre, RS, Brazil
关键词
leiomyoma; myometrium; insulin-like growth factor 1 receptor; tyrosine kinase;
D O I
10.1159/000076690
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Uterine leiomyomas are the most common tumors of the genital tract. Growth factors seem to be implicated in the development of leiomyoma. The aim of this study was to determine insulin-like growth factor 1 receptor (IGF-1-R) mRNA levels and IGF-1-R tyrosine kinase activity in normal myometrium and leiomyoma. Plasma membranes of myometrium and leiomyoma of 14 women subjected to hysterectomy were prepared, and samples were incubated in the absence or presence of recombinant human IGF-1 to assess the tyrosine kinase activity (Western blot). Reverse-transcriptase polymerase chain reaction with specific primers for IGF-1-R was used to determine IGF-1-R mRNA levels. IGF-1-R mRNA levels in myometrium (0.8216+/-0.096 ) and in leiomyoma (0.7905+/-0.136) were not statistically significantly different (p=0.648). The degree of IGF-1-R autophosphorylation stimulated by recombinant IGF-1 was not different in myometrium (1.020+/-0.120) and leiomyoma (1.620+/-0.656) either (p=0.075). There was no difference in IGF-1-R expression and IGF-1-R autophosphorylation between normal myometrium and leiomyoma. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:210 / 213
页数:4
相关论文
共 50 条
  • [31] The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy
    Chegini, N
    Luo, XP
    Ding, L
    Ripley, D
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 209 (1-2) : 9 - 16
  • [32] HIGH-AFFINITY INSULIN BINDING TO AN ATYPICAL INSULIN-LIKE GROWTH FACTOR-I RECEPTOR IN HUMAN BREAST-CANCER CELLS
    MILAZZO, G
    YIP, CC
    MADDUX, BA
    VIGNERI, R
    GOLDFINE, ID
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) : 899 - 908
  • [33] The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance
    Jennifer M. Gross
    Douglas Yee
    Cancer and Metastasis Reviews, 2003, 22 : 327 - 336
  • [34] Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer
    Fidler, Mary Jo
    Basu, Sanjib
    Buckingham, Lela
    Walters, Kelly
    Mccormack, Sharon
    Batus, Marta
    Coon, John
    Bonomi, Philip
    ANTICANCER RESEARCH, 2012, 32 (05) : 1705 - 1710
  • [35] The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance
    Gross, JM
    Yee, D
    CANCER AND METASTASIS REVIEWS, 2003, 22 (04) : 327 - 336
  • [36] LMP1 Promotes Expression of Insulin-Like Growth Factor 1 (IGF1) To Selectively Activate IGF1 Receptor and Drive Cell Proliferation
    Tworkoski, Kathryn
    Raab-Traub, Nancy
    JOURNAL OF VIROLOGY, 2015, 89 (05) : 2590 - 2602
  • [37] Expression of Mucin-1, Galectin-1 and Galectin-3 in Human Leiomyosarcoma in Comparison to Leiomyoma and Myometrium
    Weissenbacher, Tobias
    Kuhn, Christina
    Mayr, Doris
    Pavlik, Roman
    Friese, Klaus
    Scholz, Christoph
    Jeschke, Udo
    Ditsch, Nina
    Dian, Darius
    ANTICANCER RESEARCH, 2011, 31 (02) : 451 - 457
  • [38] Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
    Hewish, Madeleine
    Chau, Ian
    Cunningham, David
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (01) : 54 - 72
  • [39] Targeting insulin-like growth factor in breast cancer therapeutics
    Karamouzis, Michalis V.
    Papavassiliou, Athanasios G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 8 - 17
  • [40] Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: Potential for dual inhibition as a therapeutic modality
    Clayburgh, Daniel R.
    Gross, Neil D.
    Proby, Charlotte
    Koide, Jade
    Wong, Melissa H.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (01): : 86 - 93